EUVIMEDEUVIMED entdecken
Crossref

Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis

Shunichi Fujita, Kazuhisa Nakano iD, Akiko Nagasu, Sumie Hiramatsu-Asano, Takahiko Akagi, Yoshitaka Morita

International Journal of Rheumatic Diseases · 2024

DOI: 10.1111/1756-185x.15069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Shunichi Fujita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Kawasaki Medical School, Kurashiki, Okayama, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Arthritis, Rheumatoid, Lung Diseases, Interstitial, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Kawasaki Medical School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To clarify the prognosis and prognostic factors for lung cancer in patients with rheumatoid arthritis (RA).

Methods

In this retrospective longitudinal study, we investigated the medical records of patients with RA among 1422 patients diagnosed with lung cancer and registered in a hospital‐based cancer registry between January 2013 and May 2022. The Kaplan–Meier method and Cox proportional hazards model were used to analyze survival and identify predictive factors.

Results

Of 26 patients with RA complicated with lung cancer (median age, 69 years), the 2‐year overall survival rates for stages I–II were 90%–100%, and those for stages III–IV were 20%, respectively. Positivity of anti‐citrullinated protein/peptide antibody, smoking history, interstitial lung disease, poorly controlled RA, stage III and IV lung cancer, histological types other than adenocarcinoma and squamous cell carcinoma, and RF ≧ 50 IU/mL were associated with increased mortality. After the surgical resection of stage I and II lung cancer, 5 of the 16 patients experienced cancer recurrence after resumption of RA treatment, and the histology of the recurrent cancers was mostly squamous cell carcinoma.

Conclusions

Early detection of lung cancer is needed, especially in patients with RA who have a history of smoking, seropositivity, or interstitial lung disease. Even after surgical resection, it should be noted that squamous cell carcinoma is prone to recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsArthritis, RheumatoidLung Diseases, InterstitialCarcinoma, Squamous CellHumansAgedPrognosisRetrospective StudiesLongitudinal StudiesNeoplasm Recurrence, LocalAnti-Citrullinated Protein Antibodies

Stichwörter der Autor:innen

lung cancerprognosisrelapserheumatoid arthritissquamous cell carcinoma

Substanzen

Anti-Citrullinated Protein Antibodies

Autor:innen und Institutionen

  • Department of Rheumatology, Kawasaki Medical School, Kurashiki, Okayama, Japan.

ORCID-Profile: Kazuhisa Nakano

Förderung

  • Kawasaki Medical School

Zitieren

APA

Fujita, S., Nakano, K., Nagasu, A., Hiramatsu-Asano, S., Akagi, T., & Morita, Y. (2024). Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15069

Vancouver

Fujita S, Nakano K, Nagasu A, Hiramatsu-Asano S, Akagi T, Morita Y. Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15069

BibTeX
@article{Fujita2024,
  author = {Fujita, Shunichi and Nakano, Kazuhisa and Nagasu, Akiko and Hiramatsu-Asano, Sumie and Akagi, Takahiko and Morita, Yoshitaka},
  title = {Prognosis and prognostic factors of lung cancer complications in patients with rheumatoid arthritis},
  journal = {International Journal of Rheumatic Diseases},
  year = {2024},
  doi = {10.1111/1756-185x.15069}
}
Kostenlos starten →